Skip to content

Clinical trials

Hepatitis B trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Country / region: Singapore Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20051
20062
20071
20081
20091
20102
20141
20152
20161
20171
20191
20202
20212
20225
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Active, not recruiting2
Recruiting2
Terminated2
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline6
Bristol-Myers Squibb3
Gilead Sciences2
Alnylam Pharmaceuticals1
Assembly Biosciences1
AusperBio Therapeutics Inc.1
Brii Biosciences Limited1
F-star Therapeutics, Inc.1
Inovio Pharmaceuticals1
Lion TCR Pte. Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B29
Hepatitis B, Chronic19
Hepatitis6
Hepatitis, Chronic3
Carcinoma, Hepatocellular2
Chronic Disease2
DNA Virus Infections2
Digestive System Diseases2
Hepatitis, Viral, Human2
Liver Diseases2

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.